Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access               Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain KITE message board posts where the ticker symbol KITE has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest KITE SEC Filings

Filings Format Description Filing Date File/Film Number
15-12B  Documents Securities registration termination [Section 12(b)]
Acc-no: 0001193125-17-309956 (34 Act)  Size: 9 KB
2017-10-13 001-36508
UPLOAD  Documents [Cover]SEC-generated letter
Acc-no: 0000000000-17-036237 Size: 35 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-17-056240 Size: 19 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-17-056239 Size: 13 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-17-056237 Size: 24 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-17-056236 Size: 22 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-17-056235 Size: 15 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-17-056234 Size: 19 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-17-056233 Size: 18 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001209191-17-056232 Size: 20 KB
More KITE SEC Filings

Related news from
Thu, 18 Jan 2018
12:45:10 +0000
No Reason To Rush Into Juno Therapeutics Inc Stock After This Big Pop
Juno Therapeutics Inc (NASDAQ:JUNO) stock is up about 50% after the Wall Street Journal reported on Tuesday that biotech giant Celgene Corporation (NASDAQ:CELG) is in talks to buy the company. Juno Therapeutics is a pioneer in the booming cell therapy industry, where biotech companies are developing modified human immune cells to combat cancer cells.
Tue, 02 Jan 2018
19:39:52 +0000
5 Companies Reach 52-Week Highs
A number of companies have achieved annual milestones
Fri, 29 Dec 2017
12:00:00 +0000
Why Gilead Sciences Stock Should Be Avoided in 2018
Gilead's foray into the adoptive cell-therapy space doesn't bode well for its prospects next year.
Fri, 15 Dec 2017
18:07:31 +0000
Don't Count on Gilead Buying Galapagos
The drugmaker needs a deal, but this European biotech isn't it.
Fri, 08 Dec 2017
14:43:02 +0000
Gilead Sciences to Acquire Cell Design Labs for $567 Million
Gilead Sciences, (GILD) and its subsidiary Kite announced that they have inked an agreement to acquire Cell Design Labs, for an upfront payment of $175 million.
Fri, 01 Dec 2017
10:05:00 +0000
Gene Therapy Is Booming, But How Will We Manage The Costs?
Three leading executives in the booming field of gene therapy debated the question of whether the pricey therapies should be reimbursed based on whether or not they cure patients.
Thu, 30 Nov 2017
22:16:36 +0000
Does Gilead's Kite Acquisition Offer A New Buying Opportunity?
Gilead caught an upgrade following its Kite buyout and the promise shown with new cancer drugs.
Thu, 30 Nov 2017
18:58:47 +0000
Maxim Explains Why Gilead Sciences Is A Now A Buy
Gilead Sciences, Inc. (NASDAQ: GILD ) stands to benefit on multiple fronts, which prompted an analyst to upgrade the shares of the company Thursday. The Analyst Maxim Group analyst Jason McCarthy upgraded ...
Thu, 30 Nov 2017
18:13:29 +0000
Gilead Sciences Stock Upgraded: This Is the Power of Free
Wall Street cannot resist buying a stock on sale -- and for better or worse, Gilead often seems to be on sale.
Tue, 14 Nov 2017
20:03:41 +0000
7 Life Science Stocks to Buy Today
Biotech and life sciences stocks have had a great run-up so far in 2017. Through the end of October, the S&P Biotechnology Select Sector Industry Index (SPSIBI) is up 52%. That makes the life science stocks some of best performers around. And what’s not to like?
Thu, 02 Nov 2017
05:00:11 +0000
Juno touts latest cancer drug results after rivals win FDA approval
Juno Therapeutics Inc. has announced new cancer trial results that could help the drugmaker leapfrog key competitors in the rapidly emerging cancer immunotherapy industry. Juno said the latest data from its lead product candidate, called JCAR017, are stronger than from Novartis Pharmaceuticals Corp. and Kite Pharma Inc. Both rivals recently won Food and Drug Administration approval to start selling their CAR-T (chimeric antigen receptor T cell) treatments. "There's been this odd belief that all CAR-Ts are the same," Juno President of Research and Development Dr. Sunil Agarwal said Wednesday.
Tue, 24 Oct 2017
19:24:00 +0000
3 Healthcare Value Stocks
It might be hard to find value-priced healthcare stocks, but Gilead Sciences, Masimo, and AbbVie qualify if investors know how to look at them.
Thu, 19 Oct 2017
17:03:40 +0000
Gilead shares up after FDA approves breakthrough cancer treatment
The FDA has approved a new cancer treatment developed by Gilead's $11B acquisition Kite Pharma. Yahoo Finance’s Alexis Christoforous, Rick Newman, and Nicole Sinclair have more.
Tue, 17 Oct 2017
12:39:06 +0000
Gilead Sciences on the Street: Analyst Recommendations in October
Of the 28 analysts tracking Gilead Sciences in October 2017, three have recommended a “strong buy,” while 11 have recommended a “buy."
Mon, 16 Oct 2017
12:01:09 +0000
6 Top Biotech Companies In Innovation Earn Recognition In New Awards
Cancer. Alzheimer’s. MS. Treatments from the fast-growing U.S. biotech industry provide new hope for patients. What are the top biotech companies in innovation?
Mon, 16 Oct 2017
11:45:07 +0000
Kite Pharma Cancer Treatment Stands Out In Hot CAR-T Field
Gilead's new Kite Pharma unit is a leader in cutting-edge CAR-T therapy that fights cancer by rebuilding a patient's cells. Here's how its treatment stands out and who it helps.

"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "ValueForum is a great group of very smart, sophisticated investors. We have several professionals on board managing millions of dollars, and "average Joe" investors that beat the pants off of Wall Street professionals year in and year out. ValueForum will expose you to a wealth of ideas and sectors, and keep you ahead of the curve." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards